Population
Patients with diabetes and animal models of Type 1 and Type 2 diabetes
Design
Review
Authors
Loading...
Metabolic shifts may drive diabetic cardiomyopathy; leaves open whether substrate modulation improves outcomes.
Alterations in cardiac metabolism, specifically augmented fatty acid and decreased glucose consumption, are key contributors to the development of diabetic cardiomyopathy.
Ding et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: